Molecular modeling and structure-based drug discovery approach reveals protein kinases as off-targets for novel anticancer drug RH1.
about
Molecular modeling and structure-based drug discovery approach reveals protein kinases as off-targets for novel anticancer drug RH1.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Molecular modeling and structu ...... for novel anticancer drug RH1.
@en
Molecular modeling and structu ...... for novel anticancer drug RH1.
@nl
type
label
Molecular modeling and structu ...... for novel anticancer drug RH1.
@en
Molecular modeling and structu ...... for novel anticancer drug RH1.
@nl
prefLabel
Molecular modeling and structu ...... for novel anticancer drug RH1.
@en
Molecular modeling and structu ...... for novel anticancer drug RH1.
@nl
P2860
P50
P1433
P1476
Molecular modeling and structu ...... for novel anticancer drug RH1
@en
P2093
Dalius Kuciauskas
Shanker Lal Kothari
P2860
P2888
P356
10.1007/S12032-017-1011-5
P577
2017-09-06T00:00:00Z